Alterations in expressed prostate secretion-urine PSA N-glycosylation discriminate prostate cancer from benign prostate hyperplasia

The prostate specific antigen (PSA) test is widely used for early diagnosis of prostate cancer (PCa). However, its limited sensitivity has led to over-diagnosis and over-treatment of PCa. Glycosylation alteration is a common phenomenon in cancer development. Different PSA glycan subforms have been p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Gaozhen, Dong, Zhenyang, Sun, Chenxia, Wen, Fuping, Wang, Haifeng, Guo, Huaizu, Gao, Xu, Xu, Chuanliang, Yang, Chenghua, Sun, Yinghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652757/
https://www.ncbi.nlm.nih.gov/pubmed/29100363
http://dx.doi.org/10.18632/oncotarget.20299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652757/
https://www.ncbi.nlm.nih.gov/pubmed/29100363
http://dx.doi.org/10.18632/oncotarget.20299

Ejemplares similares